Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis
Glucagon-like Peptide-1 (GLP1) is a 30 amino acid peptide that stimulates insulin only when the blood glucose level is high, hence the risk of hypoglycemia is substantially minimized
The obesity-MS connection: why weight loss matters The relationship between obesity and MS is well-established
Top 25th percentile of 1,597 Noom Med users (Full-Dose compounded): average weight loss of 25 pounds Top 25th percentile of 1,185 Noom Med users (Microdose compounded): average weight loss of 13 pounds Noom states users lose 48% more weight in 6 months compared to those taking GLP-1 medications without Noom's behavior-change program, based on a retrospective self-reported study of 387 participants Compounded medication outcomes cannot be directly compared to FDA-approved Wegovy or Zepbound clinical trial outcomes compounded products are not reviewed by the FDA for safety, effectiveness, or quality
The key here is supplements according to the National Institutes of Health, theyre not intended to replace a healthy diet or prescribed medications, or treat, prevent, or cure diseases
